iCAD to Join Forces with Radiology Partners, the Nation’s Largest Radiology Practice
10 nov. 2022 16h01 HE
|
iCAD, Inc.
NASHUA, N.H., Nov. 10, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the first...
iCAD to Report Third Quarter 2022 Financial Results on November 10, 2022
27 oct. 2022 08h40 HE
|
iCAD, Inc.
NASHUA, N.H., Oct. 27, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...
iCAD and Solis Mammography Ink Deal to Collaborate on Use of AI to Evaluate Risk of Cardiovascular Disease
11 oct. 2022 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Oct. 11, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced a new...
iCAD To Participate in The Lake Street Capital Markets 6th Annual Best Ideas Growth (BIG6) Conference on September 14, 2022
07 sept. 2022 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Sept. 07, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the...
iCAD Customers in the U.S. and Europe Increasingly Adopting Company’s Full Suite of Breast AI Technologies via Subscription Model
29 août 2022 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Aug. 29, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that a...
iCAD Reports Financial Results For Second Quarter 2022
10 août 2022 16h07 HE
|
iCAD, Inc.
Company reports accelerating demand for subscription and cloud-based business models driving long-term recurring revenue opportunities Cancer Detection revenue grew 10.4% compared to the second...
iCAD to Report Second Quarter 2022 Financial Results on August 10, 2022
27 juil. 2022 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., July 27, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...
iCAD Presents its Complete Suite of Breast Cancer AI Solutions at the European Congress of Radiology
13 juil. 2022 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., July 13, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that the...
ProFound AI Risk Real-World Case Studies to be featured in iCAD’s “ProFound Insights, ProFound Impact” Webinar Series
29 juin 2022 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., June 29, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that...
iCAD’s “ProFound Insights, ProFound Impact” Webinar Series to Highlight ProFound AI Risk
07 juin 2022 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., June 07, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced its next...